Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Laboratorios Farmaceuticos ROVI SA, ticker ROVI, is a Spain-based pharmaceutical company primarily engaged in developing, manufacturing, and commercializing pharmaceutical products. The company's activities span both domestic and international markets, focusing on a range of medical and drug treatments. Founded in 1946, ROVI continues to expand its reach and influence in the healthcare and pharmaceutical sectors.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Laboratorios Farmaceuticos RoviAbbVie
Last price
€58.08$285.42
Currency
EUR
USD
€2.9B$501B
16.0580.06
€3.62$3.54
0.230.28
€0.78$6.83
1.34%2.44%
Sector
HealthHealth
Employees
2,47057,000
Ticker
€ROVI$ABBV
Primary listing
BMENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €ROVI or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.